Antibody profiles to wheat germ cell-free system synthesized Plasmodium falciparum proteins correlate with protection from symptomatic malaria in Uganda (Q36250121)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Antibody profiles to wheat germ cell-free system synthesized Plasmodium falciparum proteins correlate with protection from symptomatic malaria in Uganda	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

13 August 2017

Antibody profiles to wheat germ cell-free system synthesized Plasmodium falciparum proteins correlate with protection from symptomatic malaria in Uganda (English)

1 reference

Europe PubMed Central

13 August 2017

0 references

Plasmodium falciparum

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Michael T. White

object named as

Michael T White

4

0 references

Bernard N Kanoi

object named as

Bernard N Kanoi

1

0 references

Nirianne Marie Q Palacpac

5

object named as

Nirianne M Q Palacpac

1 reference

Europe PubMed Central

13 August 2017

Betty Balikagala

7

object named as

Betty Balikagala

1 reference

Europe PubMed Central

13 August 2017

Toshihiro Horii

object named as

Toshihiro Horii

10

0 references

Takafumi Tsuboi

object named as

Takafumi Tsuboi

11

0 references

author name string

Eizo Takashima

2

1 reference

Europe PubMed Central

13 August 2017

Masayuki Morita

3

1 reference

Europe PubMed Central

13 August 2017

Edward H Ntege

6

1 reference

Europe PubMed Central

13 August 2017

Adoke Yeka

8

1 reference

Europe PubMed Central

13 August 2017

Thomas G Egwang

9

1 reference

Europe PubMed Central

13 August 2017

language of work or name

0 references

publication date

12 January 2017

1 reference

Europe PubMed Central

13 August 2017

1 reference

Europe PubMed Central

13 August 2017

35

1 reference

Europe PubMed Central

13 August 2017

873-881

1 reference

Europe PubMed Central

13 August 2017

6

1 reference

Europe PubMed Central

13 August 2017

Drug resistance. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Artemisinin Resistance in Plasmodium falciparum Malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Immunity to non-cerebral severe malaria is acquired after one or two infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Patterns in age-specific malaria incidence in a population exposed to low levels of malaria transmission intensity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Mechanisms of defense against P. falciparum asexual blood stages in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

STUDIES IN THE ACQUISITION OF IMMUNITY OF PLASMODIUM FALCIPARUM INFECTIONS IN AFRICA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Parasitologic and clinical human response to immunoglobulin administration in falciparum malaria.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Clinical immunity to malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Progress and prospects for blood-stage malaria vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

A field trial to assess a blood-stage malaria vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Demonstration of the Blood-Stage Plasmodium falciparum Controlled Human Malaria Infection Model to Assess Efficacy of the P. falciparum Apical Membrane Antigen 1 Vaccine, FMP2.1/AS01

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

New antigens for a multicomponent blood-stage malaria vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Profiling humoral immune responses to P. falciparum infection with protein microarrays

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Identification and prioritization of merozoite antigens as targets of protective human immunity to Plasmodium falciparum malaria for vaccine and biomarker development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Plasmodium falciparum Protein Microarray Antibody Profiles Correlate With Protection From Symptomatic Malaria in Kenya

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Novel approaches to identify protective malaria vaccine candidates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Plasmodium vivax: comparison of immunogenicity among proteins expressed in the cell-free systems of Escherichia coli and wheat germ by suspension array assays

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

High-throughput generation of P. falciparum functional molecules by recombinational cloning

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Genome-scale protein expression and structural biology of Plasmodium falciparum and related Apicomplexan organisms.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Wheat germ cell-free system-based production of malaria proteins for discovery of novel vaccine candidates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Application of wheat germ cell-free protein expression system for novel malaria vaccine candidate discovery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Practical cell-free protein synthesis system using purified wheat embryos

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Discovery of GAMA, a Plasmodium falciparum merozoite micronemal protein, as a novel blood-stage vaccine candidate antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Simple screening method for autoantigen proteins using the N-terminal biotinylated protein library produced by wheat cell-free synthesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Phase 1b randomized trial and follow-up study in Uganda of the blood-stage malaria vaccine candidate BK-SE36.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Continuing intense malaria transmission in northern Uganda

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Malaria in Uganda: challenges to control on the long road to elimination: I. Epidemiology and current control efforts

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Variation in malaria transmission intensity in seven sites throughout Uganda.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Breadth of anti-merozoite antibody responses is associated with the genetic diversity of asymptomatic Plasmodium falciparum infections and protection against clinical malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Acquired immunity to malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

The merozoite surface protein 6 gene codes for a 36 kDa protein associated with the Plasmodium falciparum merozoite surface protein-1 complex.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Systematic genetic analysis of the Plasmodium falciparum MSP7-like family reveals differences in protein expression, location, and importance in asexual growth of the blood-stage parasite

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Binding of Plasmodium merozoite proteins RON2 and AMA1 triggers commitment to invasion

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Merozoite surface protein 1 recognition of host glycophorin A mediates malaria parasite invasion of red blood cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Antibodies to pre-erythrocytic Plasmodium falciparum antigens and risk of clinical malaria in Kenyan children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Correlation of high levels of antibodies to multiple pre-erythrocytic Plasmodium falciparum antigens and protection from infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Discovery of Novel Plasmodium falciparum Pre-Erythrocytic Antigens for Vaccine Development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Temperature shift and host cell contact up-regulate sporozoite expression of Plasmodium falciparum genes involved in hepatocyte infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Strain-transcending immune response generated by chimeras of the malaria vaccine candidate merozoite surface protein 2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Plasmodium falciparum rhoptry neck protein 5 peptides bind to human red blood cells and inhibit parasite invasion

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Identification of GAPDH on the surface of Plasmodium sporozoites as a new candidate for targeting malaria liver invasion

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Surface export of GAPDH/SDH, a glycolytic enzyme, is essential for Streptococcus pyogenes virulence

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Vaccine candidates for malaria: what's new?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Enhancing blockade of Plasmodium falciparum erythrocyte invasion: assessing combinations of antibodies against PfRH5 and other merozoite antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Clinical protection from falciparum malaria correlates with neutrophil respiratory bursts induced by merozoites opsonized with human serum antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Identifiers

10.1016/J.VACCINE.2017.01.001

1 reference

Europe PubMed Central

13 August 2017

1 reference

Europe PubMed Central

13 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36250121&oldid=1982136427"